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Abstract
Introduction Despite an increasing implantation rate of
interspinous process distraction (IPD) devices in the
treatment of intermittent neurogenic claudication (INC),
deﬁnitive evidence on the clinical effectiveness of implants
is lacking. The main objective of this review was to per-
form a meta-analysis of all systematic reviews, randomized
clinical trials and prospective cohort series to quantify the
effectiveness of IPDs and to evaluate the potential side-
effects.
Methods Data from all studies prospectively describing
clinical results based on validated outcome scales and
reporting complications of treatment of patients with INC
with IPD placement. We searched MEDLINE, EMBASE,
Web of Science, Cochrane (CENTRAL), CINAHL, Aca-
demic Search Premier, Science Direct up to July 2010.
Studies describing patients with INC caused by lumbar
stenosis, reporting complication rate and reporting based
on validated outcome scores, were eligible. Studies with
only instrumented IPD results were excluded.
Results Eleven studies eligible studies were identiﬁed.
Two independently RCTs and eight prospective cohorts
were available. In total 563 patients were treated with IPDs.
All studies showed improvement in validated outcome
scores after 6 weeks and 1 year. Pooled data based on the
Zurich Claudication Questionnaire of the RCTs were more
in favor of IPD treatment compared with conservative
treatment (pooled estimate 23.2, SD 18.5–27.8). Statistical
heterogeneity after pooled data was low (I-squared 0.0,
p = 0.930). Overall complication rate was 7%.
Conclusion As the evidence is relatively low and the
costs are high, more thorough (cost-) effectiveness studies
should be performed before worldwide implementation is
introduced.
Keywords Degenerative  Lumbar spinal  Stenosis 
IPD  Effectiveness  Meta-analysis  Complications
Introduction
Intermittent neurogenic claudication (INC) is a complex of
symptoms, the most important being leg pain and numb-
ness (frequently in both legs) with possibly associated back
pain [1–4]. The symptoms can be diminished by ﬂexion of
the lumbar spine [5–8]. Lumbar spinal arthrosis inducing
arthrosis of the facet is associated with INC [8, 9]. Tradi-
tionally, bony decompression of the canal and the lateral
recessus seems to be the golden standard in the treatment of
INC [3, 4]. There is some evidence that bony decompres-
sion is a proven superior therapy compared with non-sur-
gical therapy, such as steroid injections or physiotherapy
[10, 11]. Less invasive strategies have been developed to
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laminotomy or endoscopic procedures [12]. Although sur-
gery is frequently offered, detailed outcome results are not
available and spine surgeons try to develop innovative less
invasive surgical approaches to gain better outcome than
the results observed in daily practice.
Parallel to these developments, interspinous implants for
interspinous process distraction devices (IPD) have been
developed to achieve indirect decompression [13, 14]. The
design of the implants aims at limitation of lumbar
extension and increasing the interlaminar space of the
affected level [15–19]. Nowadays, the technique is widely
used. Kyphon Inc. had a worldwide X-STOP
TM
net sale, in
the ﬁrst quarter of 2007, of 18.1 million USD. Paradigm
Spine Inc. reported in May 2010 a worldwide sale of
13,128 Coﬂex
TM
devices in 2009 [20]. The existing evi-
dence seems to be poor; almost no comparative studies
between conventional surgical decompression and surgery
with IPD are done [17, 21–24]. Some claim, performing
IPD placement in day surgery and with local anesthesia
will lower the costs. However, a thorough cost-analysis has
never been performed.
The main objective of this systematic review was to
evaluate if surgery with IPD is more effective compared
with bony decompression in the treatment of patients with
INC or at least more effective compared with conservative
(e.g. steroid injections) treatment.
Methods
This systematic review was performed according to the
Cochrane systematic review methodology, up-dated by
Furlan and Van Tulder and the Meta-analysis of Observa-
tional Studies in Epidemiology (MOOSE) criteria [25–27].
Search strategies
On July 1, 2010, a search of relevant systematic reviews on
IPD in the Cochrane Library and, in addition, observational
cohort studies (with and without control group), systematic
reviews and randomized clinical trials was conducted in
MEDLINE, EMBASE, Web of Science, Cochrane (CEN-
TRAL), CINAHL, Academic Search Premier, Science
Direct. Keywords used for the search were: interspinous
implant surgery, interspinous implants, interspinous dis-
traction devices, interspinous decompression device,
interspinous process decompression, intermittent neuro-
genic claudication, neurogenic claudication, lumbar ste-
nosis, or spinal stenosis. The full search strategy is
available upon request from the corresponding author.
References of retrieved articles and relevant overview
articles were checked to identify additional studies.
Inclusion criteria
Prospective cohort studies, systematic reviews and/or
RCTs written in English were considered eligible for
inclusion if they fulﬁlled all of the following:
1. The study population consists of patients with INC
caused by lumbar stenosis.
2. Patients with INC without or with degenerative
spondylolisthesis to a maximal grade I.
3. One of the treatments consists of non-instrumented
IPD for treating symptoms of INC (excluding pedicle
screw ﬁxations combined with IPD).
4. A validated outcome score is used to evaluate the
outcome after surgery, the Zurich Claudication Ques-
tionnaire or the Modiﬁed Roland Disability Question-
naire for Sciatica, Oswestry Disability Index, VAS leg
and back pain [28–39].
Studies, in which subgroups met our inclusion criteria,
were included in our results if the results for these sub-
populations were reported separately.
Study selection
Two reviewers independently applied the inclusion criteria
to select potential relevant studies from the titles and
abstracts or if necessary the complete publication of the
references retrieved by the literature search. Where nec-
essary, a third reviewer was consulted to resolve a
disagreement.
Categorization of the relevant literature
Relevant literature was categorized under three different
headers: systematic reviews, RCTs, and prospective cohort
studies of high quality. The header ‘systematic reviews’
describes all systematic reviews. The header ‘RCTs’ con-
tains all published RCTs on the same intervention com-
paring IPD with decompression or conservative treatment.
Additional prognostic cohort studies were included. The
header ‘observational cohort studies’ contains all pro-
spective cohorts with adequate description of the follow-up
period and validated outcome measurements. When, due to
lack of evidence, pooling data was not possible a
descriptive review would be performed based on RCTs and
prospective observational cohort studies.
Methodological quality assessment
Systematic reviews were validated using the steps deﬁned
by Furlan and Van Tulder [27, 40]. To identify potential
risks of bias of the included RCTs two reviewers inde-
pendently assessed the methodological quality of each
Eur Spine J (2011) 20:1596–1606 1597
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adapted by Furlan and Van Tulder [25, 27, 41, 42]. Each
item was scored as ‘‘yes’’, ‘‘no’’, or ‘‘don’t’ know’’. High
quality was deﬁned as a score of 50% or more on the
methodological quality assessment. The Dutch Cochrane
Centre Quality Assessment (DCCQA) scale was used for
the validation process for observational studies. According
to the Dutch Cochrane Centre Quality Assessment scale, a
score below six was deﬁned as low methodological quality
on the DCCQA scale. A third reviewer could be consulted
to solve disagreement between the reviewers.
Data extraction
Independently, data were extracted by two reviewers.
Information was collected on the study population, inter-
vention(s) performed, outcome measures and outcome. The
follow-up time was categorized into short-term outcome
(6 weeks after intervention) and long-term outcome (at
least 1 year). Furthermore, complication rate and device
failure (a re-intervention or other surgical technique was
necessary) were recorded. Despite the often mentioned
spinal process fractures, all other causes for surgical re-
interventions were also recorded [43–46].
Outcome measurements
There are various classiﬁcations to describe neurological
and functional outcome of patients with intermittent neu-
rogenic claudication. Articles were ﬁltered on presence of
one of the four mostly used outcome scales. Firstly, articles
were included on the Zurich Claudication Questionnaire
(ZCQ), also known as the Brigham Spinal Stenosis Ques-
tionnaire and Swiss Spinal Stenosis Questionnaire [35, 38,
39]. The ZCQ scale consists of three subscales: symptom
severity, physical function and patient satisfaction. Domain
scores ranges from 1 to 5, 1 to 4, and 1 to 4, respectively.
Like in the study of Tuli in 2006, we chose threshold scores
for each scale based on prior work [35, 38, 39, 47]. In the
symptom severity scale and in the physical function scale
the minimal clinically important difference (MCID) is 0.5
[38, 39]. A mean patient satisfaction score of less than 2.5
has been shown previously to represent a satisﬁed patient
[38, 39]. Secondly, articles were used on the Modiﬁed
Roland Disability Questionnaire for Sciatica (MRDQ). The
23-points MRDQ is the most widely used patient-assessed
measure of health for low back pain and leg pain [29–34,
36]. This questionnaire consists of 23 questions with higher
scores indicating increased disability [48]. The Visual
Analog Scale (VAS) is one of the most used follow-up
measurement tools for back pain and leg pain [49]. This
parameter will measure the experienced back and leg pain
intensity in the week before visiting the research nurse.
Pain will be assessed on a horizontal 100 mm scale varying
from 0 mm, ‘‘no pain’’, to 100 mm, ‘‘the worst pain
imaginable’’ [49]. This parameter has a MCID of two
points on a scale of 0 to 10 [50]. Finally, the Oswestry
disability index (ODI), where 0 indicates no disability and
100 indicates worst possible disability, was included for
our analysis [51]. This parameter has a MCID of 10.0–12.4
points [50, 52, 53].
Data synthesis
A meta-analysis was performed if two or more RCTs were
available with clinical homogeneous patient groups and
statistical homogeneous results. When not possible, due to
small amount of studies or heterogeneity, a best-evidence
synthesis was used. Best-evidence synthesis was performed
stratiﬁed for studies meeting 50% or more opposed to those
meeting less than 50% of the quality criteria of the Van
Tulder list [27]. The study was only included in the best-
evidence synthesis if a comparison was made between the
groups (IPD placement vs. conservative treatment or IPD
placement vs. surgical decompressive treatment). When
meta-analysis or best-evidence synthesis based on RCT is
not possible, a data extraction based on observational
studies (with or without control group) will be performed.
Although a high risk of bias is possible, if possible we
performed a data extraction from observational studies
based on the ‘‘best-of-the-rest’’ principle.
Results
Study selection
The search revealed 253 references. 222 articles were
excluded on the basis of the abstract, title and keywords. 20
articles were excluded after reading the complete articles
because of the following reasons: the reports did not con-
sist original patient data (4) [17, 23, 54, 55], articles were
not written in English (2) [56, 57], there were no outcome
results given (9) [24, 58–65], studies with a retrospective
study design (5) [43, 66–69]. As a result, only three RCTs
and eight prospective cohorts were included for methodo-
logical quality assessment in this review (Fig. 1, Flow-
chart) [17, 21–23, 70–76].
Description of study characteristics
No systematic reviews could be found. Three reports of
randomized clinical trials (RCTs) and eight prospective
cohorts were found. Three reports described two RCTs
comparing non-operative treatment to treatment with IPD;
one observational cohort described IPD treatment versus
1598 Eur Spine J (2011) 20:1596–1606
123non-operative treatment after bony decompression in both
groups; seven cohorts described treatment with IPD only.
Two RCTs described the results of the same patient sam-
ple. The ﬁrst study published follow-up data after 1 year
and the last published study after 2 years, both are shown
in Table 1 [17, 23].
Methodological quality assessment
The methodological quality of the studies is summarized
in Tables 1 and 2. Two reports of one RCT (of the three
RCTs) had a methodological quality score of 5 (low
quality) and one RCT had a quality of 6 (a high quality
study) according to the Furlan and Van Tulder criteria
[25, 27]. Only one observational study had a methodo-
logical quality of 6 out of 8 (reﬂecting high quality)
[76], thus the remaining 7 observational studies are of
low methodological quality and with high risk of bias
[22, 70–75].
Data extraction
In Tables 3, 4 and 5, relevant data on the selected studies is
shown with the baseline and postoperative follow-up scores
at 6 weeks and 1 year. Two RCTs with different patients
samples (the two RCTs of Zucherman were conducted on
the same patient sample), Anderson et al. and Zucherman
et al. [17, 21], could be used for best evidence synthesis.
Both RCTs compared conservative treatment with IPD
placement (Fig. 2, meta-analysis). Both studies measured
follow-up data on the ZCQ. In the study by Zucherman
et al., however, overall success rates and standard deviation
(SD) values were not shown. A calculation was made,
based on the ZCQ values of symptom severity and physical
function ZCQ. SD values were calculated estimated from
the SD values of Anderson et al. Both studies favored
treatment with IPD placement, pooled ZCQ improvement
by 23.2 (SD 18.5–27.8). Statistical heterogeneity after
pooled data was low (I-squared 0.0, p = 0.930). According
Literature search 1st of July 2010 (N=253)
Medline 106; Embase 38
Web of Science 31; Cochrane 5
CINAHL 13; Academic Search Premier 18
Science Direct 42
Studies retrieved (N=31)
Exclusion after
screening abstract (N=222)
Studies retrieved (N=11)
Anderson PA, Bhadra AK, Brussee P, Galarza M,
Kuchta J, Lee J, Richter A,
Siddiqui, M, Yano S, Zucherman JF (2004&2005)
Exclusion after screening 
full text (N=20)
Of which double patient groups:
Hsu, Kondrashov
Fig. 1 Flowchart
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123to the statistical heterogeneity, baseline criteria in both
studies showed a good clinical homogeneity. Richter et al.
[22] compared two surgical decompression cohorts: one
group with surgical decompression and no IPD placement,
one group with surgical decompression with IPD place-
ment. Both groups showed clinical improvement in the
ODI, MRDQ and VAS. At 6 weeks and at 1 year follow-up
there were no statistical signiﬁcantly differences between
both groups. The remaining seven prospective cohort
studies showed improvement from baseline after treatment
with IPD [70–76]. However, these groups did not compare
other treatment modalities (such as conservative treatment)
with IPD follow-up results. Due to the use of multiple
follow-up scales, pooling of data was not possible
(Tables 4, 5, prospective cohort studies).
In our search of literature, 563 patients underwent
implantation with IPD. Complication rates and device
failure rates were available from 513 patients (Table 3,
RCT, Tables 4, 5, prospective cohorts). A total of 31
devices failed (6%) and had to be replaced or were re-
operated with bony decompression and stabilization. Six
(1%) other complications were also reported (infections
and postoperative leakages).
Discussion
The literature has been systematically reviewed to evaluate
the outcome for patients with intermittent neurogenic
claudication treated with IPD versus bony decompression
or conservative non-surgical treatment. To our knowledge,
this is the ﬁrst systematic review and meta-analysis on this
subject. After a literature search, two independent RCTs
and eight prospective cohorts, one with a control group,
were eligible for validation and data extraction. The
methodological quality of the RCTs were 5 (Zucherman)
and 6 (Anderson) [17, 21]. The methodological quality of
the remaining prospective cohort studies was relatively low
(only one reached 6 out of 8) [22, 70–76]. In total 563
patients were treated with IPD. All studies showed
improvement in validated outcome scores after 6 weeks
and 1 year. Pooled data of the RCTs were more in favor of
IPD treatment compared with conservative treatment.
The review of the literature showed that very little is
known about treatment with IPD. Only one comparative
study with good methodological quality fulﬁlling our
selection criteria was found [21]. Different indications are
used for these devices, such as described by Richter who
used an IPD in combination with surgical decompression
[22]. Some studies show beneﬁcial effect of surgical
technique compared to conservative treatment for patients
with degenerative lumbar spinal stenosis and neurogenic
intermittent claudication [10, 11]. More centers, however,
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123perform complex techniques rather than only a decom-
pression technique. Between 2002 and 2007, complex
fusion procedures showed a 15-fold increase in the USA.
Furthermore, the overall procedure rate slightly decreased
with 1.4% [77–79]. Coﬂex worldwide implants increased
from 1,717 in 2005 to 13,128 in 2009. Even without evi-
dence of implantation of an IPD as a treatment strategy for
INC, some centers use it in a combination with other
techniques [22]. Despite the fact that no arguments exist in
the literature about the effectiveness of treatment with IPD
versus bony decompression, many centers throughout the
world use IPD for the treatment of INC.
Overall complication and failure rate of (7%, including
6% reoperations rate after device failure) tended to be
relatively low compared to the complication rate of stan-
dard bony decompression. For example, Weinstein and
Malmivaara [10, 11] reported a complication rate of
17–24% in the standard bony decompression operation
cohorts. The most frequently reported complications in
these series are dural tears and wrong level surgery. Due to
the use of standard X-rays in the operation theater with IPD
treatment, wrong level surgery in interspinous decom-
pression surgery is rare. Most techniques of interspinous
decompression are indirect and with some distance from
the dura, therefore causing a dural tear is difﬁcult by reg-
ular surgical methods. Despite the large numbers of case
reports on complications after IPD treatment, complication
rates tends to be low [43, 44, 80, 81]. This, however, might
be induced by selection bias of published studies. Despite
the relatively low complication rate, device failure rate
needing reoperation is high (6%). This number can be
higher because of the publication bias, but also the lack of
long-term follow-up. This conclusion is difﬁcult to conﬁrm
due to the fact that no comparative studies are done on this
subject. Combined with the 6% device failure rate com-
plication rate, the IPD complication rate is 7%. In the lit-
erature, implantation surgery is associated with
complication rate of 8% (2–6% failure rate) [79]. The
complication rate would be possible higher when compli-
cations would be monitored 30 days after discharge. Not
all studies included in our review reported complication
rate 30 days after hospital stay. Prospective reporting of
complication should be made standard in future trials.
The most important limitation of this review concerned
the methodological weaknesses and selection biases of the
included studies: the vast majority was observational,
without independent outcome assessment, and without
complications well deﬁned. Additionally, we combined
two different RCTs for our meta-analysis [17, 21]. Both
studies did not mention a thorough power or sample size
design, resulting in a 191 patients in one RCT and 75 in the
other. Furthermore, only one study was of relatively high
methodological quality. Therefore, possible information
bias could be introduced. Furthermore we excluded 242
studies, introducing selection bias. Due to the retrospective
design of some of these studies, possible interesting patient
data had to be excluded. Studies that were published in
abstract or poster format only were excluded. The present
study was aimed at identifying published peer-reviewed
literature, so that inﬂuence of publication bias cannot be
ruled out. Due to the small number of studies, possible
publication bias (using e.g. funnel plot) could not ade-
quately be assessed. Due to the anticipated low number of
RCTs, prospective studies were also included. Most of
these studies were of low methodological quality (Table 2,
Validation). Due to the inclusion of studies of low meth-
odological quality, information bias is easily introduced.
Furthermore, methodological quality assessment does not
take into account the author’s disclosure. For example, two
studies in our review stated that one of the authors is a
consultant and, in one article, stockholder of the company
manufacturing the IPD device they were using for their
study [21, 70]. The remaining studies did not mention any
conﬂict of interest or disclosure. Seven studies did not even
describe the possible conﬂicts of interest. Assessing pos-
sible conﬂict of interest is not incorporated in both
Fig. 2 Meta-analysis. IPD interspinous process decompression, SD standard deviation, WMD weighted mean difference
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123validation scales [25, 27]. Standard adjusting both scales
based on possible conﬂict of interest is advisable.
This review of the literature shows that surgical decom-
pression with interspinous process devices is superior to
conservative non-surgical treatment in patients with lumbar
degenerativespinalstenosiswithINC.However,thelevelof
evidence for this conclusion is debatable due to the low
qualityofsomeoftheincludedstudies.Furthermore,nodata
is presently available comparing interspinous process
decompression with standard bony decompression. We
suggest that more studies will be done on this subject
comparing the surgical treatment with IPD versus bony
decompression. Despite the fact that we could give a Grade
A recommendation, according to the Oxford-Centre for
Evidence Based Medicine, we suggest that further studies
have to be performed before a thorough recommendation
can be given regarding the treatment of INC with IPDs [82].
These studies should also include analysis on complication
rate and device failure rate. As the evidence is relatively low
and the costs are high, more thorough cost-effectiveness
studies should be performed before worldwide implemen-
tation is introduced. Because the golden standard for surgi-
cal decompression seems to be absent, patients with lumbar
spinal stenosis should be guarded against instrumented
surgeryortheuseofIPDonthebasisofthecurrentevidence.
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